Interferon-γ inhibits STAT6 signal transduction and gene expression in human airway epithelial cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 31, Issue 5, 2004, Pages 573-582

  Heller, Nicola M ^a   Matsukura, Satoshi ^b   Georas, Steve N ^b   Boothby, Mark R ^b   Rothman, Paul B ^b   Stellato, Cristiana ^b   Schleimer, Robert P ^b  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; LUCIFERASE; MESSENGER RNA; STAT6 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ALLERGY; ARTICLE; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

B-LYMPHOCYTES; BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; CYTOKINES; CYTOPLASM; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; GENETIC VECTORS; HUMANS; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-4; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES; TH2 CELLS; TIME FACTORS; TRACHEA; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION;

STAPHYLOCOCCUS PHAGE 3A;

EID: 7744220818     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2004-0195OC     Document Type: Article

References (78)

1. Ahdieh, M., T. Vandenbos, and A. Youakim. 2001. Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma. Am. J. Physiol. Cell Physiol. 281:C2029-C2038.
2. Gavett, S. H., D. J. O'Hearn, C. L. Karp, E. A. Patel, B. H. Schofield, F. D. Finkelman, and M. Wills-Karp. 1997. Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am. J. Physiol. 272:L253-L261.
3. Blyth, D. I., M. S. Pedrick, T. J. Savage, E. M. Hessel, and D. Fattah. 1996. Lung inflammation and epithelial changes in a murine model of atopic asthma. Am. J. Respir. Cell Mol. Biol. 14:425-438.
4. Temann, U. A., B. Prasad, M. W. Gallup, C. Basbaum, S. B. Ho, R. A. Flavell, and J. A. Rankin. 1997. A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am. J. Respir. Cell Mol. Biol. 16:471-478.
5. Jelihovsky, T. 1983. The structure of bronchial plugs in mucoid impaction, bronchocentric granulomatosis and asthma. Histopathology 7:153-167.
6. Zheng, T., Z. Zhu, W. Liu, C. G. Lee, Q. Chen, R. J. Homer, and J. A. Elias. 2003. Cytokine regulation of IL-13Ralpha2 and IL-13Ralpha1 in vivo and in vitro. J. Allergy Clin. Immunol. 111:720-728.
7. Lee, J. H., N. Kaminski, G. Dolganov, G. Grunig, L. Koth, C. Solomon, D. J. Erle, and D. Sheppard. 2001. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am. J. Respir. Cell Mol. Biol. 25:474-485.
8. Lilly, C. M., H. Nakamura, H. Kesselman, C. Nagler-Anderson, K. Asano, E. A. Garcia-Zepeda, M. E. Rothenberg, J. M. Drazen, and A. D. Luster. 1997. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J. Clin. Invest. 99:1767-1773.
9. Stellato, C., S. Matsukura, A. Fal, J. White, L. A. Beck, D. Proud, and R. P. Schleimer. 1999. Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J. Immunol. 163:5624-5632.
10. Zimmermann, N., S. P. Hogan, A. Mishra, E. B. Brandt, T. R. Bodette, S. M. Pope, F. D. Finkelman, and M. E. Rothenberg. 2000. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J. Immunol. 165:5839-5846.
11. Ying, S., Q. Meng, K. Zeibecoglou, D. S. Robinson, A. Macfarlane, M. Humbert, and A. B. Kay. 1999. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J. Immunol. 163:6321-6329.
12. Banwell, M. E., N. S. Tolley, T. J. Williams, and T. J. Mitchell. 2002. Regulation of human eotaxin-3/CCL26 expression: modulation by cytokines and glucocorticoids. Cytokine 17:317-323.
13. Garcia-Zepeda, E. A., C. Combadiere, M. E. Rothenberg, M. N. Sarafi, F. Lavigne, Q. Hamid, P. M. Murphy, and A. D. Luster. 1996. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and non-allergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J. Immunol. 157:5613-5626.
14. Stellato, C., P. Collins, P. D. Ponath, D. Soler, W. Newman, G. La Rosa, H. Li, J. White, L. M. Schwiebert, C. Bickel, M. Liu, B. S. Bochner, T. Williams, and R. P. Schleimer. 1997. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J. Clin. Invest. 99:926-936.
15. Sekiya, T., M. Miyamasu, M. Imanishi, H. Yamada, T. Nakajima, M. Yamaguchi, T. Fujisawa, R. Pawankar, Y. Sano, K. Ohta, A. Ishii, Y. Morita, K. Yamamoto, K. Matsushima, O. Yoshie, and K. Hirai. 2000. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J. Immunol. 165:2205-2213.
16. van der Velden, V. H., B. A. Naber, A. F. Wierenga-Wolf, R. Debets, H. F. Savelkoul, S. E. Overbeek, H. C. Hoogsteden, and M. A. Versnel. 1998. Interleukin 4 receptors on human bronchial epithelial cells: an in vivo and in vitro analysis of expression and function. Cytokine 10:803-813.
17. Daines, M. O., and G. K. Hershey. 2002. A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses: evidence for intracellular stores of IL-13 receptor alpha-2 and their rapid mobilization by interferon-gamma. J. Biol. Chem. 277:10387-10393.
18. Yasunaga, S., N. Yuyama, K. Arima, H. Tanaka, S. Toda, M. Maeda, K. Matsui, C. Goda, Q. Yang, Y. Sugita, H. Nagai, and K. Izuhara. 2003. The negative-feedback regulation of the IL-13 signal by the IL-13 receptor alpha2 chain in bronchial epithelial cells. Cytokine 24:293-303.
19. Hou, J., U. Schindler, W. J. Henzel, T. C. Ho, M. Brasseur, and S. L. McKnight. 1994. An interleukin-4-induced transcription factor: IL-4 STAT. Science 265:1701-1706.
20. Schindler, C., H. Kashleva, A. Pernis, R. Pine, and P. Rothman. 1994. STF-IL-4: a novel IL-4-induced signal transducing factor. EMBO J. 13:1350-1356.
21. Kotanides, H., and N. C. Reich. 1993. Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 262:1265-1267.
22. Schindler, U., P. Wu, M. Rothe, M. Brasseur, and S. L. McKnight. 1995. Components of a STAT recognition code: evidence for two layers of molecular selectivity. Immunity 2:689-697.
23. Kuperman, D., B. Schofield, M. Wills-Karp, and M. J. Grusby. 1998. Signal transducer and activator of transcription factor 6 (STAT6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J. Exp. Med. 187:939-948.
24. Kuperman, D. A., X. Huang, L. L. Koth, G. H. Chang, G. M. Dolganov, Z. Zhu, J. A. Elias, D. Sheppard, and D. J. Erle. 2002. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8:885-889.
25. Kelly-Welch, A. E., M. E. Melo, E. Smith, A. Q. Ford, C. Haudenschild, N. Noben-Trauth, and A. D. Keegan. 2004. Complex role of the IL-4 receptor alpha in a murine model of airway inflammation: expression of the IL-4 receptor alpha on nonlymphoid cells of bone marrow origin contributes to severity of inflammation. J. Immunol. 172:4545-4555.
26. Chung, F. 2001. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma. Mediators Inflamm. 10:51-59.
27. Martin, R. J., M. Boguniewicz, J. E. Henson, A. C. Celniker, M. Williams, R. C. Giorno, and D. Y. Leung. 1993. The effects of inhaled interferon gamma in normal human airways. Am. Rev. Respir. Dis. 148:1677-1682.
28. Lack, G., K. L. Bradley, E. Hamelmann, H. Renz, J. Loader, D. Y. Leung, G. Larsen, and E. W. Gelfand. 1996. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J. Immunol. 157:1432-1439.
29. Leonard, P., and S. Sur. 2003. Interleukin-12: potential role in asthma therapy. BioDrugs 17:1-7.
30. Wen, F. Q., X. D. Liu, Y. Terasaki, Q. H. Fang, T. Kobayashi, S. Abe, and S. I. Rennard. 2003. Interferon-gamma reduces interleukin-4- and interleukin-13-augmented transforming growth factor-beta2 production in human bronchial epithelial cells by targeting Smads. Chest 123(Suppl):372S-373S.
31. Sigal, E., D. L. Sloane, and D. J. Conrad. 1993. Human 15-lipoxygenase: induction by interleukin-4 and insights into positional specificity. J. Lipid Mediat. 6:75-88.
32. Dickensheets, H. L., and R. P. Donnelly. 1999. Inhibition of IL-4-inducible gene expression in human monocytes by type I and type II interferons. J. Leukoc. Biol. 65:307-312.
33. Mikita, T., D. Campbell, P. Wu, K. Williamson, and U. Schindler. 1996. Requirements for interleukin-4-induced gene expression and functional characterization of STAT6. Mol. Cell. Biol. 16:5811-5820.
34. Matsukura, S., C. Stellate, J. R. Plitt, C. Bickel, K. Miura, S. N. Georas, V. Casolaro, and R. P. Schleimer. 1999. Activation of eotaxin gene transcription by NF-kappaB and STAT6 in human airway epithelial cells. J. Immunol. 163:6876-6883.
35. Puddicombe, S. M., R. Polosa, A. Richter, M. T. Krishna, P. H. Howarth, S. T. Holgate, and D. E. Davies. 2000. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J. 14:1362-1374.
36. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
37. Fujisawa, T., Y. Kato, J. Atsuta, A. Terada, K. Iguchi, H. Kamiya, H. Yamada, T. Nakajima, M. Miyamasu, and K. Hirai. 2000. Chemokine production by the BEAS-2B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by TH2- and TH1-derived cytokines. J. Allergy Clin. Immunol. 105:126-133.
38. Matsukura, S., F. Kokubu, H. Kuga, M. Kawaguchi, K. Ieki, M. Odaka, S. Suzuki, S. Watanabe, H. Takeuchi, M. Adachi, C. Stellato, and R. P. Schleimer. 2003. Differential regulation of eotaxin expression by IFN-gamma in airway epithelial cells. J. Allergy Clin. Immunol. 111:1337-1344.
39. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005-2007.
40. Chen, Y. H., A. P. Bieneman, P. S. Creticos, K. L. Chichester, and J. T. Schroeder. 2003. IFN-alpha inhibits IL-3 priming of human basophil cytokine secretion but not leukotriene C4 and histamine release. J. Allergy Clin. Immunol. 112:944-950.
41. Simon, H. U., H. Seelbach, R. Ehmann, and M. Schmitz. 2003. Clinical and immunological effects of low-dose IFN-alpha treatment in patients with corticosteroid-resistant asthma. Allergy 58:1250-1255.
42. Heller, N. M., S. Matsukura, S. N. Georas, M. R. Boothby, C. Stellato, and R. P. Schleimer. 2002. Regulation of signal transducer and activator of transcription 6, by glucocorticoids and cytokines. FASEB J. 16:A1222 (Abstr.)
43. Dickensheets, H. L., C. Venkataraman, U. Schindler, and R. P. Donnelly. 1999. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proc. Natl. Acad. Sci. USA 96:10800-10805.
44. So, E. Y., H. H. Park, and C. E. Lee. 2000. IFN-gamma and IFN-alpha posttranscriptionally down-regulate the IL-4-induced IL-4 receptor gene expression. J. Immunol. 165:5472-5479.
45. Bonder, C. S., K. V. Davies, E. K. Hosszu, J. J. Finlay-Jones, and P. H. Hart. 2002. IFN-gamma downregulates interleukin-4 functional activity on monocytes by multiple mechanisms. J. Interferon Cytokine Res. 22:287-293.
46. David, M., D. Ford, J. Bertoglio, A. L. Maizel, and J. Pierre. 2001. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways. Oncogene 20:6660-6668.
47. Rahaman, S. O., P. Sharma, P. C. Harbor, M. J. Aman, M. A. Vogelbaum, and S. J. Haque. 2002. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells. Cancer Res. 62:1103-1109.
48. Losman, J. A., X. P. Chen, D. Hilton, and P. Rothman. 1999. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction. J. Immunol. 162: 3770-3774.
49. Haque, S. J., P. C. Harbor, and B. R. Williams. 2000. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling. J. Biol. Chem. 275:26500-26506.
50. Seki, Y., K. Hayashi, A. Matsumoto, N. Seki, J. Tsukada, J. Ransom, T. Naka, T. Kishimoto, A. Yoshimura, and M. Kubo. 2002. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc. Natl. Acad. Sci. USA 99:13003-13008.
51. Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921.
52. Gatto, L., C. Berlato, V. Poli, S. Tininini, I. Kinjyo, A. Yoshimura, M. A. Cassatella, and F. Bazzoni. 2004. Analysis of SOCS-3 promoter responses to interferon gamma. J. Biol. Chem. 279:13746-13754.
53. Yoshikawa, H., K. Matsubara, G. S. Qian, P. Jackson, J. D. Groopman, J. E. Manning, C. C. Harris, and J. G. Herman. 2001. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 28: 29-35.
54. Ren, E. C., L. Y. Wong, and S. H. Chan. 1988. Effect of recombinant gamma interferon on hepatocellular carcinoma cell lines. Cancer Lett. 39:305-310.
55. Tatsumi, T., T. Takehara, K. Katayama, K. Mochizuki, M. Yamamoto, T. Kanto, Y. Sasaki, A. Kasahara, and N. Hayashi. 1997. Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma. Hepatology 25:1108-1114.
56. Sehgal, P. B., G. G. Guo, M. Shah, V. Kumar, and K. Patel. 2002. Cytokine signaling: STATS in plasma membrane rafts. J. Biol. Chem. 277:12067-12074.
57. Lee, C. E., S. R. Yoon, and K. H. Pyun. 1993. Mechanism of interferon-gamma down-regulation of the interleukin 4-induced CD23/Fc epsilon RII expression in human B cells: post-transcriptional modulation by interferon-gamma. Mol. Immunol. 30:301-307.
58. Radzioch, D., and L. Varesio. 1991. c-fos mRNA expression in macrophages is downregulated by interferon-gamma at the posttranscriptional level. Mol. Cell. Biol. 11:2718-2722.
59. Bourgeade, M. F., F. Silbermann, L. Kuhn, U. Testa, C. Peschle, S. Memet, M. N. Thang, and F. Besancon. 1992. Post-transcriptional regulation of transferrin receptor mRNA by IFN gamma. Nucleic Acids Res. 20:2997-3003.
60. Shankaranarayanan, P., P. Chaitidis, H. Kuhn, and S. Nigam. 2001. Acetylation by histone acetyltransferase CREB-binding protein/p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene. J. Biol. Chem. 276:42753-42760.
61. Chen, W., M. O. Daines, and G. K. Khurana Hershey. 2003. Arginine 27, a conserved methylation site in STAT6, is essential for IL-4-induced tyrosine phosphorylation, DNA binding activity, and nuclear translocation of STAT6. J. Allergy Clin. Immunol. 111:8855 (Abstr.)
62. Gonalons, E., M. Barrachina, J. A. Garcia-Sanz, and A. Celada. 1998. Translational control of MHC class II I-A molecules by IFN-gamma. J. Immunol. 161:1837-1843.
63. Diaz, A., and S. A. Jimenez. 1997. Interferon-gamma regulates collagen and fibronectin gene expression by transcriptional and post-transcriptional mechanisms. Int. J. Biochem. Cell Biol. 29:251-260.
64. Sampath, P., B. Mazumder, V. Seshadri, and P. L. Fox. 2003. Transcript-selective translational silencing by gamma interferon is directed by a novel structural element in the ceruloplasmin mRNA 3′ untranslated region. Mol. Cell. Biol. 23:1509-1519.
65. Brand, K., N. Mackman, and L. K. Curtiss. 1993. Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms. J. Clin. Invest. 91:2031-2039.
66. Kawakami, K., J. Taguchi, T. Murata, and R. K. Puri. 2001. The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. Blood 97:2673-2679.
67. Wood, N., M. J. Whitters, B. A. Jacobson, J. Witek, J. P. Sypek, M. Kasaian, M. J. Eppihimer, M. Unger, T. Tanaka, S. J. Goldman, M. Collins, D. D. Donaldson, and M. J. Grusby. 2003. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J. Exp. Med. 197:703-709.
68. McKenzie, A. N., and P. G. Fallon. 2003. Decoy receptors in the regulation of T helper cell type 2 responses. J. Exp. Med. 197:675-679.
69. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J. G. Giri, S. K. Dower, J. E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472-475.
70. Haudenschild, D., T. Moseley, L. Rose, and A. H. Reddi. 2002. Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer. J. Biol. Chem. 277:4309-4316.
71. Elewaut, D., L. Brossay, S. M. Santee, O. V. Naidenko, N. Burdin, H. De Winter, J. Matsuda, C. F. Ware, H. Cheroutre, and M. Kronenberg. 2000. Membrane lymphotoxin is required for the development of different subpopulations of NK T cells. J. Immunol. 165:671-679.
72. Pitti, R. M., S. A. Marsters, D. A. Lawrence, M. Roy, F. C. Kischkel, P. Dowd, A. Huang, C. J. Donahue, S. W. Sherwood, D. T. Baldwin, P. J. Godowski, W. I. Wood, A. L. Gurney, K. J. Hillan, R. L. Cohen, A. D. Goddard, D. Botstein, and A. Ashkenazi. 1998. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396:699-703.
73. Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelley, M. S. Chang, R. Luthy, H. Q. Nguyen, S. Wooden, L. Bennett, T. Boone, G. Shimamoto, M. DeRose, R. Elliott, A. Colombero, H. L. Tan, G. Trail, J. Sullivan, E. Davy, N. Bucay, L. Renshaw-Gegg, T. M. Hughes, D. Hill, W. Pattison, P. Campbell, S. Sander, G. Van J. Tarpley, P. Derby, R. Lee, and W. J. Boyle. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
74. Caput, D., P. Laurent, M. Kaghad, J. M. Lelias, S. Lefort, N. Vita, and P. Ferrara. 1996. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J. Biol. Chem. 271:16921-16926.
75. Cornish, A. L., M. M. Chong, G. M. Davey, R. Darwiche, N. A. Nicola, D. J. Hilton, T. W. Kay, R. Starr, and W. S. Alexander. 2003. Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other gamma c-dependent cytokines in peripheral T cells. J. Biol. Chem. 278:22755-22761.
76. Hebenstreit, D., P. Luft, A. Schmiedlechner, G. Regl, A. M. Frischauf, F. Aberger, A. Duschl, and J. Horejs-Hoeck. 2003. IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site. J. Immunol. 171:5901-5907.
77. Sato, T., R. Saito, T. Jinushi, T. Tsuji, J. Matsuzaki, T. Koda, S. Nishimura, H. Takeshima, and T. Nishimura. 2004. IFN-gamma-induced SOCS-1 regulates STAT6-dependent eotaxin production triggered by IL-4 and TNF-alpha. Biochem. Biophys. Res. Commun. 314:468-475.
78. Wilusz, C. J., M. Wormington, and S. W. Peltz. 2001. The cap-to-tail guide to mRNA turnover. Nat. Rev. Mol. Cell Biol. 2:237-246.